Uma Sinha Insider Trading $EIDX Eidos Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Uma Sinha.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Uma Sinha. Uma Sinha is Chief Scientific Officer in Eidos Therapeutics, Inc. ($EIDX) and Chief Scientific Officer in BridgeBio Pharma, Inc. ($BBIO).
Uma Sinha in Eidos Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Uma Sinha: Chief Scientific Officer
Holdings: 303,525 shares
Latest Transaction: Jan 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Uma Sinha in Eidos Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | D | 13.20 | 60,000 | 792,000 | 0 | |
| Jan 28 2021 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | U | 0.00 | 303,525 | 0 | 0 | 303.5 K to 0 (-100.00 %) |
| Jan 28 2021 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Gift | G | 0.00 | 3,000 | 0 | 303,525 | 306.5 K to 303.5 K (-0.98 %) |
| Jan 15 2021 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 126.39 | 300 | 37,917 | 306,525 | 306.8 K to 306.5 K (-0.10 %) |
| Jan 15 2021 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 125.35 | 2,000 | 250,700 | 306,825 | 308.8 K to 306.8 K (-0.65 %) |
| Jan 15 2021 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 124.72 | 4,934 | 615,362 | 308,825 | 313.8 K to 308.8 K (-1.57 %) |
| Jan 15 2021 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 123.48 | 1,498 | 184,971 | 313,759 | 315.3 K to 313.8 K (-0.48 %) |
| Jan 15 2021 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 122.27 | 572 | 69,937 | 315,257 | 315.8 K to 315.3 K (-0.18 %) |
| Jan 15 2021 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 121.11 | 696 | 84,292 | 315,829 | 316.5 K to 315.8 K (-0.22 %) |
| Dec 04 2020 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 92.97 | 200 | 18,593 | 316,525 | 316.7 K to 316.5 K (-0.06 %) |
| Dec 04 2020 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 91.89 | 300 | 27,567 | 316,725 | 317 K to 316.7 K (-0.09 %) |
| Dec 04 2020 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 90.63 | 702 | 63,625 | 317,025 | 317.7 K to 317 K (-0.22 %) |
| Dec 04 2020 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 89.63 | 3,798 | 340,402 | 317,727 | 321.5 K to 317.7 K (-1.18 %) |
| Oct 02 2020 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 52.35 | 4,831 | 252,923 | 326,525 | 331.4 K to 326.5 K (-1.46 %) |
| Oct 02 2020 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 52.00 | 100 | 5,200 | 331,356 | 331.5 K to 331.4 K (-0.03 %) |
| Oct 02 2020 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 52.08 | 69 | 3,594 | 331,456 | 331.5 K to 331.5 K (-0.02 %) |
| Dec 20 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 63.31 | 1,702 | 107,761 | 331,081 | 332.8 K to 331.1 K (-0.51 %) |
| Dec 20 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 62.49 | 825 | 51,553 | 332,783 | 333.6 K to 332.8 K (-0.25 %) |
| Dec 20 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 61.61 | 9,973 | 614,480 | 333,608 | 343.6 K to 333.6 K (-2.90 %) |
| Sep 27 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 39.15 | 100 | 3,915 | 343,581 | 343.7 K to 343.6 K (-0.03 %) |
| Sep 27 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 38.38 | 2,400 | 92,101 | 343,681 | 346.1 K to 343.7 K (-0.69 %) |
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 38.35 | 33 | 1,266 | 346,081 | 346.1 K to 346.1 K (-0.01 %) |
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 37.31 | 700 | 26,117 | 346,114 | 346.8 K to 346.1 K (-0.20 %) |
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 36.53 | 1,300 | 47,485 | 346,814 | 348.1 K to 346.8 K (-0.37 %) |
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 35.65 | 2,967 | 105,760 | 348,114 | 351.1 K to 348.1 K (-0.85 %) |
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Grant | A | 12.01 | 1,769 | 21,247 | 351,081 | 349.3 K to 351.1 K (+0.51 %) |
| May 28 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 27.88 | 800 | 22,304 | 349,312 | 350.1 K to 349.3 K (-0.23 %) |
| May 28 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 27.16 | 4,200 | 114,072 | 350,112 | 354.3 K to 350.1 K (-1.19 %) |
| May 28 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Grant | A | 12.01 | 1,081 | 12,983 | 354,312 | 353.2 K to 354.3 K (+0.31 %) |
| Nov 07 2018 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | A | 13.20 | 60,000 | 792,000 | 60,000 |
Page: 1